Automated Classification of Body MRI Sequence Type Using Convolutional Neural Networks

Kimberly Helm1, Tejas Sudharshan Mathai1, Boah Kim1

  • 1Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

Arxiv
|March 26, 2024
PubMed

Insights

This study introduces an automated method to classify 3D Magnetic Resonance Imaging (MRI) sequences in the chest, abdomen, and pelvis. Our AI model accurately identifies MRI sequences, reducing the need for manual review in clinical studies and AI development.

Area of Science:

  • Radiology and Medical Imaging
  • Artificial Intelligence in Healthcare
  • Medical Informatics

Background:

  • Multi-parametric MRI is crucial for disease diagnosis, but lacks standardized naming conventions for protocols and sequences.
  • Variations in imaging practices and MRI scanner manufacturers lead to differing intensity distributions and conflicting DICOM header information.
  • Current reliance on clinician oversight for accurate sequence identification hinders large-scale clinical studies and AI algorithm development.

Approach:

  • Developed an automated 3D DenseNet-121 model for classifying MRI sequences in the chest, abdomen, and pelvis.
  • The model was trained and validated on data from three Siemens MRI scanners.
  • Evaluated the model's performance in differentiating five common MRI sequences.

Key Points:

  • Achieved a 99.5% F1 score in differentiating common MRI sequences.
  • Demonstrated the model's effectiveness across different Siemens scanner models.
  • Established a novel automated method for 3D MRI sequence classification.

Conclusions:

  • The proposed automated method significantly reduces the need for manual clinician oversight in MRI sequence identification.
  • This approach ensures the validity of DICOM headers, crucial for clinical research and AI applications.
  • Outperformed previous state-of-the-art methods for MRI series classification.